Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Bertolino, A. Articles by Nardini, M. Search for Related Content PubMed Citation Articles by Bertolino, A. Articles by Nardini, M. Schizophrenia Spectrum Disorders Cognition Neurodegeneration

Working Memory Deficits and Levels of N-Acetylaspartate in Patients With Schizophreniform Disorder

OBJECTIVE: The authors used proton magnetic resonance spectroscopic imaging (¹H-MRSI) to assess potential reductions of N-acetylaspartate (a marker of neuronal integrity) in the hippocampal area and dorsolateral prefrontal cortex of patients with schizophreniform disorder. In addition, they assessed the relationship between N-acetylaspartate levels and working memory deficits. METHOD: Twenty-four patients with DSM-IV schizophreniform disorder and 24 healthy subjects were studied. Subjects underwent ¹H-MRSI and were given the N-back working memory test. RESULTS: The schizophreniform disorder patients had selective reductions of N-acetylaspartate ratios in the hippocampal area and the dorsolateral prefrontal cortex, and a positive correlation was seen between N-acetylaspartate ratios in the dorsolateral prefrontal cortex and performance during the 2-back working memory condition. CONCLUSIONS: Similar to findings reported in schizophrenia studies, N-acetylaspartate reductions in the hippocampal area and the dorsolateral prefrontal cortex were seen in patients with schizophreniform disorder. Moreover, the results support other evidence that neuronal pathology in the dorsolateral prefrontal cortex accounts for a proportion of working memory deficits already present at illness outset.

This article has been cited by other articles:

				S. J. Wood, G. E. Berger, M. Lambert, P. Conus, D. Velakoulis, G. W. Stuart, P. Desmond, P. D. McGorry, and C. Pantelis Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry, September 1, 2006; 63(9): 969 - 976. [Abstract] [Full Text] [PDF]

				S. A. SPENCE, R. D. GREEN, I. D. WILKINSON, and M. D. HUNTER Modafinil modulates anterior cingulate function in chronic schizophrenia The British Journal of Psychiatry, July 1, 2005; 187(1): 55 - 61. [Abstract] [Full Text] [PDF]

				A. Bertolino, G. Caforio, G. Blasi, M. De Candia, V. Latorre, V. Petruzzella, M. Altamura, G. Nappi, S. Papa, J. H. Callicott, et al. Interaction of COMT Val108/158 Met Genotype and Olanzapine Treatment on Prefrontal Cortical Function in Patients With Schizophrenia Am J Psychiatry, October 1, 2004; 161(10): 1798 - 1805. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us